Figure 7.
In vivo anticancer efficacy study in squamous cell carcinoma-bearing xenograft model. (A) Tumor volume measurement. (B) Hematoxylin and eosin histology staining analysis. The animals were treated with respective formulations (unbound RSV, RSV-L and RSV-GL) and the experiments were initiated when the tumor volumes reached ~100 mm3. ***P<0.0001 vs. RSV. RSV, resveratrol; GE11, dodecapeptide YHWYGYTPQNVI; RSV-L, RSV-loaded liposome; GL, GE11-conjugated liposomes.